5-hydroxymethyldeoxycytidine monophosphate has been researched along with Fanconi Anemia in 1 studies
*Fanconi Anemia: Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Calderón, CB; Klimašauskas, S; Moreno-Gordillo, P; Narmontė, M; Peña-Gómez, MJ; Rosado, IV; Rukšėnaitė, A | 1 |
1 other study(ies) available for 5-hydroxymethyldeoxycytidine monophosphate and Fanconi Anemia
| Article | Year |
|---|---|
FANCD2 maintains replication fork stability during misincorporation of the DNA demethylation products 5-hydroxymethyl-2'-deoxycytidine and 5-hydroxymethyl-2'-deoxyuridine.
Topics: Deoxycytidine; DNA Demethylation; DNA Replication; Fanconi Anemia; Fanconi Anemia Complementation Group D2 Protein; Humans; Thymidine | 2022 |